Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 1/20 | 0.61 |
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3329009 | 0.81 | PSIP1 (0.64) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6757831 | 0.80 | PSIP1 (0.56) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL777601 | 0.78 | PSIP1 (0.67) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL64761 | 0.78 | PSIP1 (0.67) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2454944 | 0.77 | PSIP1 (0.58) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL17838799 | 0.77 | PSIP1 (0.52) | PSIP1HTR6HSD11B1ALDH1A1CA2 | |
| SCHEMBL180713 | 0.76 | PSIP1 (1.00) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL14347652 | 0.75 | PSIP1 (0.56) | PSIP1HTR6HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL14393403 | 0.75 | ENPP2 (0.50) | PSIP1ALDH1A1GAA | |
| SCHEMBL14544901 | 0.75 | MMP2 (0.45) | HSD11B1ALDH1A1CA1CA2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100335486-C | Preparation method of [(phenyl sulfonyl) difluoro methyl] trimethyl silane | SHANGHAI INST ORGANIC CHEM (CN) | 2007-09-05 | — | — | CN | claimed |
| CN-122036555-A | Trans-6, 7-disubstituted bicyclo [3.1.1] heptane and preparation method thereof | 山东大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-117088909-A | Method for producing aryltrimethylstannane compound | 上海致同建设工程科技有限公司 | 2023-11-21 | — | — | CN | disclosed |
| WO-2021078174-A1 | CHIRAL SULFUR OXIDE-CONTAINING ARYL FORMAMIDE COMPOUND AND SALT THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND APPLICATION | 青岛清原化合物有限公司 | 2021-04-29 | — | — | WO | disclosed |
| EP-2292779-B1 | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof | UNIV PENNSYLVANIA (US) | 2016-11-16 | — | — | EP | disclosed |
| US-8367713-B2 | Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-02-05 | — | — | US | disclosed |
| CN-101415716-B | Condensed imidazole derivatives as aldosterone synthase inhibitors | SPEEDEL EXPERIMENTA AG | 2012-12-12 | — | — | CN | disclosed |
| CN-101421277-A | Imidazo compounds | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-29 | — | — | CN | disclosed |
| CN-101421278-A | Condensed imidazole derivatives as aldosterone synthase inhibitors | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-29 | — | — | CN | disclosed |
| CN-101415716-A | Condensed imidazole derivatives as aldosterone synthase inhibitors | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-22 | — | — | CN | disclosed |
| WO-2007119001-A2 | AMINOMETHYL PYRIDINE DERIVATIVES, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-10-25 | — | — | WO | disclosed |
| EP-1844771-A2 | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) | Wyeth (US) | 2007-10-17 | — | — | EP | disclosed |
| EP-1397130-B1 | SUBSTITUTED INDOLE ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) | WYETH CORP (US) | 2007-07-25 | — | — | EP | disclosed |
| US-20070054939-A1 | Thiazolypiperidine derivatives as mtp inhibitors | MERCK PATNET GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070010489-A1 | Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds | GILEAD SCIENCES, INC. | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070054939-A1 | Thiazolypiperidine derivatives as mtp inhibitors | MTTP, CETP, APOB | PSIP1 1727/4885HTR6 2602/4885HSD11B1 564/4885 |
| US-20070010489-A1 | Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds | PPA1, PNP, PPME1 | PSIP1 305/4885HTR6 4046/4885HSD11B1 2819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.